Int. J. Mol. Sci. 2014, 15(1), 684-711; doi:10.3390/ijms15010684
Review

Meta-Omic Platforms to Assist in the Understanding of NAFLD Gut Microbiota Alterations: Tools and Applications

1,2
, 3
, 1,2,4
, 1,2,5
, 3
, 6
, 3,7
 and 1,2,*
Received: 10 November 2013; in revised form: 29 December 2013 / Accepted: 2 January 2014 / Published: 7 January 2014
(This article belongs to the Special Issue Non-Alcoholic Fatty Liver Disease Research)
View Full-Text   |   Download PDF [1250 KB, updated 19 June 2014; original version uploaded 19 June 2014]
Abstract: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide as a result of the increasing prevalence of obesity, starting from early life stages. It is characterized by a spectrum of liver diseases ranging from simple fatty liver (NAFL) to steatohepatitis (NASH), with a possible progression to fibrosis, thus increasing liver-related morbidity and mortality. NAFLD development is driven by the co-action of several risk factors, including obesity and metabolic syndrome, which may be both genetically induced and diet-related. Recently, particular attention has been paid to the gut-liver axis, which may play a physio-pathological role in the onset and progression of the disease. The gut microbiota is intended to act as a bioreactor that can guarantee autonomous metabolic and immunological functions and that can drive functional strategies within the environment of the body in response to external stimuli. The complexity of the gut microbiota suggests that it behaves as an organ. Therefore, the concept of the gut-liver axis must be complemented with the gut-microbiota-liver network due to the high intricacy of the microbiota components and metabolic activities; these activities form the active diet-driven power plant of the host. Such complexity can only be revealed using systems biology, which can integrate clinical phenomics and gut microbiota data.
Keywords: pediatric patients; non-alcoholic fatty liver disease; non-alcoholic steatohepatitis; obesity; metabolic syndrome; systems biology; gut microbiota; diet; meta-omic platforms; data integration
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Del Chierico, F.; Gnani, D.; Vernocchi, P.; Petrucca, A.; Alisi, A.; Dallapiccola, B.; Nobili, V.; Lorenza, P. Meta-Omic Platforms to Assist in the Understanding of NAFLD Gut Microbiota Alterations: Tools and Applications. Int. J. Mol. Sci. 2014, 15, 684-711.

AMA Style

Del Chierico F, Gnani D, Vernocchi P, Petrucca A, Alisi A, Dallapiccola B, Nobili V, Lorenza P. Meta-Omic Platforms to Assist in the Understanding of NAFLD Gut Microbiota Alterations: Tools and Applications. International Journal of Molecular Sciences. 2014; 15(1):684-711.

Chicago/Turabian Style

Del Chierico, Federica; Gnani, Daniela; Vernocchi, Pamela; Petrucca, Andrea; Alisi, Anna; Dallapiccola, Bruno; Nobili, Valerio; Lorenza, Putignani. 2014. "Meta-Omic Platforms to Assist in the Understanding of NAFLD Gut Microbiota Alterations: Tools and Applications." Int. J. Mol. Sci. 15, no. 1: 684-711.


Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert